In addition, IHC staining of tumor sections showed that exosomal lncRNA HAGLROS-treated THP-1 cells significantly decreased the expression of CD86 in tumor tissues, while increasing the expression of CD206 (Supplementary Fig. 4H). This evidence concerns the gene CD86 and neoplasm.